Literature DB >> 4961156

The selective activity of lysostaphin in vivo.

R R Martin, A White.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 4961156

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  10 in total

1.  Antigenic response to topically applied proteins.

Authors:  E F Harrison; M E Fuquay; W A Zygmunt
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

2.  Bactericidal synergy of lysostaphin in combination with antimicrobial peptides.

Authors:  A P Desbois; P J Coote
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-11       Impact factor: 3.267

3.  Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors:  K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal:  Appl Microbiol       Date:  1971-09

4.  Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model.

Authors:  John F Kokai-Kun; Scott M Walsh; Tanya Chanturiya; James J Mond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  Quantitative nasal culture: a tool in antibiotic research.

Authors:  R R Martin; A White
Journal:  Appl Microbiol       Date:  1971-09

6.  Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Authors:  M W Climo; R L Patron; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.

Authors:  P J Severance; C A Kauffman; J N Sheagren
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

8.  Lysostaphin in treatment of neonatal Staphylococcus aureus infection.

Authors:  Okunola Oluola; Lingkun Kong; Mindy Fein; Leonard E Weisman
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

9.  Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of oral therapy with erythromycin, rosamicin, and placebo.

Authors:  S Z Wilson; R R Martin; M Putman; S B Greenberg; R J Wallace; J G Jemsek
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

10.  Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.

Authors:  Anjali Shah; James Mond; Scott Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.